Gossamer Bio, Inc.
GOSS
$3.42
$0.4314.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.99% | -4.46% | -10.93% | -7.23% | -162.57% |
| Total Depreciation and Amortization | 3.29% | -37.72% | -68.19% | -2.09% | 10.69% |
| Total Amortization of Deferred Charges | 1.22% | 1.66% | 1.26% | 1.71% | -27.10% |
| Total Other Non-Cash Items | 1,232.87% | 345.04% | -114.67% | 19.95% | -25.85% |
| Change in Net Operating Assets | 130.63% | -190.23% | 38.62% | -37.03% | -106.35% |
| Cash from Operations | 23.15% | -18.47% | -11.96% | -10.76% | -127.53% |
| Capital Expenditure | 100.00% | -103.85% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -61.49% | 100.01% | -58.49% | 298.91% | 54.74% |
| Cash from Investing | -61.44% | 100.01% | -58.54% | 298.91% | 54.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | 1,891.49% | -81.35% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | 1,891.49% | -81.35% | -- | -100.00% | 103.05% |
| Foreign Exchange rate Adjustments | -173.64% | 22.86% | 184.00% | -234.41% | 1,262.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -540.71% | 84.10% | -196.84% | 130.15% | -221.66% |